Prognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer

British Journal of Surgery

Volumn 96, Issue 7, 2009, Pages 769-777

  Katoh, H ^a   Yamashita, K ^a   Sato, T ^a   Ozawa, H ^a   Nakamura, T ^a   Watanabe, M ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM TUMOR; PRIORITY JOURNAL; TUMOR CELL;

ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 67650084384     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6622     Document Type: Article

References (43)

1. Skipper D, Cooper AJ, Marston JE, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987; 74: 1049-1052.
2. Baskaranathan S, Philips J, McCredden P, Solomon MJ. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival. Dis Colon Rectum 2004; 47: 2076-2079.
3. Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I, Betsis D. Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 2003; 46: 535-539.
4. Yamamoto S, Akasu T, Fujita S, Moriya Y. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol 2003; 33: 33-37.
5. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma (13th edn). Kanehara: Tokyo, 1999.
6. Kodera Y, Nakanishi H, Yamamura Y, Shimizu Y, Torii A, Hirai T et al. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 1998; 79: 429-433.
7. Nakanishi H, Kodera Y, Tatematsu M. Molecular method to quantitatively detect micrometastases and its clinical significance in gastrointestinal malignancies. Adv Clin Chem 2004; 38: 87-110.
8. Uras C, Altinkaya E, Yardimci H, Göksel S, Yavuz N, Kaptanodlu L et al. Peritoneal cytology in the determination of free tumour cells within the abdomen in colon cancer. Surg Oncol 1996; 5: 259-263.
9. Leather AJ, Gallegos NC, Kocjan G, Savage F, Smales CS, Hu W et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993; 80: 777-780.
10. Ojima H, Sasaki S, Fujisawa T, Ishibashi Y, Masuda N, Asao T et al. Utility of serosal stamp cytology as an indicator for high-risk peritoneal metastasis in colorectal cancer surgery. Hepatogastroenterology 2003; 50: 87-90.
11. Aoki S, Takagi Y, Hayakawa M, Yamaguchi K, Futamura M, Kunieda K et al. Detection of peritoneal micrometastases by reverse transcriptase- polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J Exp Clin Cancer Res 2002; 21: 555-562.
12. Guller U, Zajac P, Schnider A, Bösch B, Vorburger S, Zuber M et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002; 236: 768-775.
13. Kanellos I, Zacharakis E, Kanellos D, Pramateftakis MG, Betsis D. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. Colorectal Dis 2006; 8: 436-440.
14. Vogel P, Rüschoff J, Kümmel S, Zirngibl H, Hofstädter F, Hohenberger W et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 2000; 43: 92-100.
15. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998; 83: 666-672.
16. Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K et al. Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer. Anticancer Res 2008; 28: 1933-1941.
17. Weitz J, D'Angelica M, Gonen M, Klimstra D, Coit DG, Brennan MF et al. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J Clin Oncol 2003; 21: 4597-4603.
18. Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Transfusion alert for patients with curable cancer. World J Surg 2007; 31: 2315-2322.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
20. Cox D. Regression models and life-tables. J R Stat Soc Ser B 1972; 34: 187-220.
21. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24: 4011-4019.
22. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991; 34: 723-727.
23. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43(Suppl): S15-S25.
24. Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol 2000; 75: 165-171.
25. Yamagata K, Kumagai K. Experimental study of lymphogenous peritoneal cancer dissemination: migration of fluorescent-labelled tumor cells in a rat model of mesenteric lymph vessel obstruction. J Exp Clin Cancer Res 2000; 19: 211-217.
26. Yamagata K, Kumagai K, Shimizu K, Masuo K, Nishida Y, Yasui A. Gastrointestinal cancer metastasis and lymphogenous spread: viewpoint of animal models of lymphatic obstruction. Jpn J Clin Oncol 1998; 28: 104-106.
27. Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K et al. Surgical resection of stage IV colorectal cancer and prognosis. World J Surg 2008; 32: 1130-1137.
28. Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003; 9: 678-685.
29. Vaccaro CA, Bonadeo FA, Benati ML, Quintana GM, Rubinstein F, Mullen E et al. Colorectal cancer staging: reappraisal of N/PN classification. Dis Colon Rectum 2004; 47: 66-69.
30. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg 1986; 203: 115-122.
31. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-3575.
32. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-8712.
33. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 2007; 14: 1712-1717.
34. Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 2007; 194: 827-831.
35. Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 2008; 15: 1600-1608.
36. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99: 433-441.
37. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-2919.
38. Ishida H, Miwa H, Tatsuta M, Masutani S, Imamura H, Shimizu J et al. Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer. Cancer Lett 2004; 207: 109-115.
39. Sobin LH, Wittekind CH (eds). International Union Against Cancer (UICC): TNM Classification of Malignant Tumors (6th edn). Wiley: New York, 2002.
40. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24: 5313-5327.
41. Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G et al. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 1998; 82: 49-59.
42. Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer 2001; 85: 692-696.
43. Ahmed IA, Kelly SB, Anderson JJ, Angus B, Challen C, Lunec J. The predictive value of p53 and p33(ING1b) in patients with Dukes' C colorectal cancer. Colorectal Dis 2008; 10: 344-351.